Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis

Abstract

Transitions between epithelial and mesenchymal phenotypes - the epithelial to -mesenchymal transition (EMT) and its reverse the mesenchymal to epithelial transition (MET) - are hallmarks of cancer metastasis. While transitioning between the epithelial and mesenchymal phenotypes, cells can also attain a hybrid epithelial/mesenchymal (E/M) (i.e., partial or intermediate EMT) phenotype. Cells in this phenotype have mixed epithelial (e.g., adhesion) and mesenchymal (e.g., migration) properties, thereby allowing them to move collectively as clusters. If these clusters reach the bloodstream intact, they can give rise to clusters of circulating tumor cells (CTCs), as have often been seen experimentally. Here, we review the operating principles of the core regulatory network for EMT/MET that acts as a "three-way" switch giving rise to three distinct phenotypes - E, M and hybrid E/M - and present a theoretical framework that can elucidate the role of many other players in regulating epithelial plasticity. Furthermore, we highlight recent studies on partial EMT and its association with drug resistance and tumor-initiating potential; and discuss how cell-cell communication between cells in a partial EMT phenotype can enable the formation of clusters of CTCs. These clusters can be more apoptosis-resistant and have more tumor-initiating potential than singly moving CTCs with a wholly mesenchymal (complete EMT) phenotype. Also, more such clusters can be formed under inflammatory conditions that are often generated by various therapies. Finally, we discuss the multiple advantages that the partial EMT or hybrid E/M phenotype have as compared to a complete EMT phenotype and argue that these collectively migrating cells are the primary "bad actors" of metastasis.

Full text

Its licence does not allow us to show the full text. Read it at PubMed Central:

References 230

1. 1.

   Hanahan D Weinberg RA Hallmarks of cancer: the next generation. Cell (2011 ) 144:646–74.

   Not in our library10.1016/j.cell.2011.02.013

2. 2.

   Lamouille S Xu J Derynck R Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol (2014 ) 15:178–96.

   Not in our library10.1038/nrm3758

3. 3.

   De Craene B Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer (2013 ) 13:97–110.

   Not in our library10.1038/nrc3447

4. 4.

   Christiansen JJ Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res (2006 ) 66:8319–26.

   Not in our library10.1158/0008-5472.can-06-0410

5. 5.

   Kalluri R Weinberg RA. Review series the basics of epithelial-mesenchymal transition. J Clin Invest (2009 ) 119:1420–8.

   Not in our library10.1172/jci39104

6. 6.

   Nieto MA. Epithelial plasticity: a common theme in embryonic and cancer cells. Science (2013 ) 342:1234850.

   Not in our library10.1126/science.1234850

7. 7.

   Gupta GP Massagué J Cancer metastasis: building a framework. Cell (2006 ) 127:679–95.

   Not in our library10.1016/j.cell.2006.11.001

8. 8.

   Revenu C Gilmour D. EMT 2.0: shaping epithelia through collective migration. Curr Opin Genet Dev (2009 ) 19:338–42.

   Not in our library10.1016/j.gde.2009.04.007

9. 9.

   Micalizzi DS Farabaugh SM Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia (2010 ) 15:117–34.

   Not in our library10.1007/s10911-010-9178-9

10. 10.

    Arnoux V Côme C Kusewitt DF Hudson LG Savagner P Cutaneous wound reepithelialization. In: Savagner P, editor. Rise and Fall of Epithelial Phenotype. Berlin: Springer (2005 ). p. 111–34.

    Not in our library

11. 11.

    Klymkowsky MW Savagner P. Epithelial-mesenchymal transition: a cancer researcher’s conceptual friend and foe. Am J Pathol (2009 ) 174:1588–93.

    Not in our library10.2353/ajpath.2009.080545

12. 12.
    Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer · 2011

    No notice
13. 13.

    Hou J-M Krebs M Ward T Sloane R Priest L Hughes A Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol (2011 ) 178:989–96.

    Not in our library10.1016/j.ajpath.2010.12.003

14. 14.

    Armstrong AJ Marengo MS Oltean S Kemeny G Bitting RL Turnbull JD Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res (2011 ) 9:997–1007.

    Not in our library10.1158/1541-7786.mcr-10-0490

15. 15.

    Yu M Bardia A Wittner BS Stott SL Smas ME Ting DT Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science (2013 ) 339:580–4.

    Not in our library10.1126/science.1228522

16. 16.
    Biology, detection, and clinical implications of circulating tumor cells · 2014

    No notice
17. 17.

    Aceto N Bardia A Miyamoto DT Donaldson MC Wittner BS Spencer JA Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell (2014 ) 158:1110–22.

    Not in our library10.1016/j.cell.2014.07.013

18. 18.
    Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival · 2015

    No notice
19. 19.

    Thiery JP Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol (2006 ) 7:131–42.

    Not in our library10.1038/nrm1835

20. 20.

    Kumar S Das A Sen S. Extracellular matrix density promotes EMT by weakening cell-cell adhesions. Mol Biosyst (2014 ) 10:838–50.

    Not in our library10.1039/c3mb70431a

21. 21.

    Brabletz S Brabletz T. The ZEB/miR-200 feedback loop – a motor of cellular plasticity in development and cancer? EMBO Rep (2010 ) 11:670–7.

    Not in our library10.1038/embor.2010.117

22. 22.

    Lu M Jolly MK Onuchic J Ben-Jacob E. Toward decoding the principles of cancer metastasis circuits. Cancer Res (2014 ) 74:4574–87.

    Not in our library10.1158/0008-5472.can-13-3367

23. 23.

    Chen L Gibbons DL Goswami S Cortez MA Ahn Y Byers LA Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat Commun (2014 ) 5:1–12.

    Not in our library10.1038/ncomms6241

24. 24.

    Pecot CV Rupaimoole R Yang D Akbani R Ivan C Lu C Tumour angiogenesis regulation by the miR-200 family. Nat Commun (2013 ) 4:2427.

    Not in our library10.1038/ncomms3427

25. 25.
    Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells · 2014

    No notice
26. 26.

    Park SM Gaur AB Lengyel E Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev (2008 ) 22:894–907.

    Not in our library10.1101/gad.1640608

27. 27.

    Burk U Schubert J Wellner U Schmalhofer O Vincan E Spaderna S A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep (2008 ) 9:582–9.

    Not in our library10.1038/embor.2008.74

28. 28.

    Bracken CP Gregory PA Kolesnikoff N Bert AG Wang J Shannon MF A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res (2008 ) 68:7846–54.

    Not in our library10.1158/0008-5472.can-08-1942

29. 29.

    Zhou JX Huang S. Understanding gene circuits at cell-fate branch points for rational cell reprogramming. Trends Genet (2011 ) 27:55–62.

    Not in our library10.1016/j.tig.2010.11.002

30. 30.

    Macía J Widder S Solé R. Why are cellular switches Boolean? General conditions for multistable genetic circuits. J Theor Biol (2009 ) 261:126–35.

    Not in our library10.1016/j.jtbi.2009.07.019

31. 31.

    Andrecut M Halley JD Winkler DA Huang S. A general model for binary cell fate decision gene circuits with degeneracy: indeterminacy and switch behavior in the absence of cooperativity. PLoS One (2011 ) 6:e19358.

    Not in our library10.1371/journal.pone.0019358

32. 32.
    Multistable Decision Switches for Flexible Control of Epigenetic Differentiation · 2008

    No notice
33. 33.

    Cherry JL Adler FR How to make a biological switch. J Theor Biol (2000 ) 203:117–33.

    Not in our library10.1006/jtbi.2000.1068

34. 34.

    Gardner TS Cantor CR Collins JJ. Construction of a genetic toggle switch in Escherichia coli. Nature (2000 ) 403:339–42.

    Not in our library10.1038/35002131

35. 35.

    Huang S Guo YP May G Enver T. Bifurcation dynamics in lineage-commitment in bipotent progenitor cells. Dev Biol (2007 ) 305:695–713.

    Not in our library10.1016/j.ydbio.2007.02.036

36. 36.

    Balázsi G Van Oudenaarden A Collins JJ. Cellular decision making and biological noise: from microbes to mammals. Cell (2011 ) 144:910–25.

    Not in our library10.1016/j.cell.2011.01.030

37. 37.
    Reprogramming cell fate: a changing story · 2014

    Not checked
38. 38.

    Graf T Enver T. Forcing cells to change lineages. Nature (2009 ) 462:587–94.

    Not in our library10.1038/nature08533

39. 39.

    Pal M Ghosh S Bose I. Non-genetic heterogeneity, criticality and cell differentiation. Phys Biol (2015 ) 12:016001.

    Not in our library10.1088/1478-3975/12/1/016001

40. 40.

    Tian X-J Zhang H Xing J. Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition. Biophys J (2013 ) 105:1079–89.

    Not in our library10.1016/j.bpj.2013.07.011

Cited by papers we hold 25

• The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis · 2022
  No notice
• Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer · 2021
  Not checked
• The transcription factor Rreb1 regulates epithelial architecture, invasiveness, and vasculogenesis in early mouse embryos · 2021
  Not checked
• Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression · 2020
  Not checked
• Quantification of the Underlying Mechanisms and Relationships Among Cancer, Metastasis, and Differentiation and Development · 2020
  Not checked
• Tracking cancer progression: from circulating tumor cells to metastasis · 2020
  No notice
• In primary airway epithelial cells, the unjamming transition is distinct from the epithelial-to-mesenchymal transition · 2020
  No notice
• EMT Factors and Metabolic Pathways in Cancer · 2020
  No notice
• HSP70 Multi-Functionality in Cancer · 2020
  No notice
• Collective cell migration and metastases induced by an epithelial-to-mesenchymal transition in Drosophila intestinal tumors · 2019
  Not checked
• The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges · 2019
  No notice
• Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution · 2019
  No notice
• Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes · 2019
  No notice
• Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells · 2019
  No notice
• Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability · 2018
  Corrected
• The Epithelial-to-Mesenchymal Transition in Cancer · 2018
  No notice
• Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States · 2018
  No notice
• EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression · 2017
  No notice
• Deciphering Epithelial–Mesenchymal Transition Regulatory Networks in Cancer through Computational Approaches · 2017
  Not checked
• Interrogating the topological robustness of gene regulatory circuits by randomization · 2017
  No notice

and 5 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.